Presentation Information

[28-14-am06]Corporate Policy Changes Following Q&A on Sales Guidelines for Ethical Drugs

○Katsunori Yamaura1, Ririka Mima1, Shingo Kondo1, Hiroki Iwata1, Noriko Kobayashi1, Shinichi Watanabe2 (1. Keio Univ. Faculty Pharm., 2. Teikyo Heisei Univ. Faculty Pharm.)